Purine metabolism in normal and thioguanine resistant neuroblastoma

A. W. Wood, M. A. Becker, J. D. Minna, J. E. Seegmiller

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purine metabolism was examined in a clonal line of mouse neuroblastoma cells resistant to the cytotoxic effects of 6 thioguanine. Comparative studies in the resistant and parental lines indicate that the former cells have less than 1% of normal hypoxanthine phosphoribosyltransferase activity. The activities of other enzymes important in the de novo and salvage pathways of purine biosynthesis were not significantly different in the 2 lines. Hypoxanthine phosphoribosyltransferase deficiency in this neuroblastoma line was associated with increased intracellular concentrations of 5 phosphoribosyl 1 pyrophosphate, an increased rate of purine biosynthesis de novo, and failure to incorporate hypoxanthine, but not adenine, into nucleotides. These are essentially the same alterations in purine metabolism that occur in hypoxanthine phosphoribosyltransferase deficient fibroblasts or lymphoblasts derived from individuals with the Lesch Nyhan syndrome. Clonal lines of hypoxanthine phosphoribosyltransferase deficient neuroblastoma cells may therefore be of use in elucidating the mechanisms by which the enzyme defect leads to the neurologic dysfunction seen in children with this disease.

Original languageEnglish (US)
JournalProceedings of the National Academy of Sciences of the United States of America
Volume70
Issue number12
StatePublished - 1973

Fingerprint

Thioguanine
Neuroblastoma
Hypoxanthine Phosphoribosyltransferase
Lesch-Nyhan Syndrome
Phosphoribosyl Pyrophosphate
Hypoxanthine
Adenine Nucleotides
Enzymes
Neurologic Manifestations
Fibroblasts
purine

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Purine metabolism in normal and thioguanine resistant neuroblastoma. / Wood, A. W.; Becker, M. A.; Minna, J. D.; Seegmiller, J. E.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 70, No. 12, 1973.

Research output: Contribution to journalArticle

@article{6fcbdca7a8184aae8a3459c38005dc8b,
title = "Purine metabolism in normal and thioguanine resistant neuroblastoma",
abstract = "Purine metabolism was examined in a clonal line of mouse neuroblastoma cells resistant to the cytotoxic effects of 6 thioguanine. Comparative studies in the resistant and parental lines indicate that the former cells have less than 1{\%} of normal hypoxanthine phosphoribosyltransferase activity. The activities of other enzymes important in the de novo and salvage pathways of purine biosynthesis were not significantly different in the 2 lines. Hypoxanthine phosphoribosyltransferase deficiency in this neuroblastoma line was associated with increased intracellular concentrations of 5 phosphoribosyl 1 pyrophosphate, an increased rate of purine biosynthesis de novo, and failure to incorporate hypoxanthine, but not adenine, into nucleotides. These are essentially the same alterations in purine metabolism that occur in hypoxanthine phosphoribosyltransferase deficient fibroblasts or lymphoblasts derived from individuals with the Lesch Nyhan syndrome. Clonal lines of hypoxanthine phosphoribosyltransferase deficient neuroblastoma cells may therefore be of use in elucidating the mechanisms by which the enzyme defect leads to the neurologic dysfunction seen in children with this disease.",
author = "Wood, {A. W.} and Becker, {M. A.} and Minna, {J. D.} and Seegmiller, {J. E.}",
year = "1973",
language = "English (US)",
volume = "70",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "12",

}

TY - JOUR

T1 - Purine metabolism in normal and thioguanine resistant neuroblastoma

AU - Wood, A. W.

AU - Becker, M. A.

AU - Minna, J. D.

AU - Seegmiller, J. E.

PY - 1973

Y1 - 1973

N2 - Purine metabolism was examined in a clonal line of mouse neuroblastoma cells resistant to the cytotoxic effects of 6 thioguanine. Comparative studies in the resistant and parental lines indicate that the former cells have less than 1% of normal hypoxanthine phosphoribosyltransferase activity. The activities of other enzymes important in the de novo and salvage pathways of purine biosynthesis were not significantly different in the 2 lines. Hypoxanthine phosphoribosyltransferase deficiency in this neuroblastoma line was associated with increased intracellular concentrations of 5 phosphoribosyl 1 pyrophosphate, an increased rate of purine biosynthesis de novo, and failure to incorporate hypoxanthine, but not adenine, into nucleotides. These are essentially the same alterations in purine metabolism that occur in hypoxanthine phosphoribosyltransferase deficient fibroblasts or lymphoblasts derived from individuals with the Lesch Nyhan syndrome. Clonal lines of hypoxanthine phosphoribosyltransferase deficient neuroblastoma cells may therefore be of use in elucidating the mechanisms by which the enzyme defect leads to the neurologic dysfunction seen in children with this disease.

AB - Purine metabolism was examined in a clonal line of mouse neuroblastoma cells resistant to the cytotoxic effects of 6 thioguanine. Comparative studies in the resistant and parental lines indicate that the former cells have less than 1% of normal hypoxanthine phosphoribosyltransferase activity. The activities of other enzymes important in the de novo and salvage pathways of purine biosynthesis were not significantly different in the 2 lines. Hypoxanthine phosphoribosyltransferase deficiency in this neuroblastoma line was associated with increased intracellular concentrations of 5 phosphoribosyl 1 pyrophosphate, an increased rate of purine biosynthesis de novo, and failure to incorporate hypoxanthine, but not adenine, into nucleotides. These are essentially the same alterations in purine metabolism that occur in hypoxanthine phosphoribosyltransferase deficient fibroblasts or lymphoblasts derived from individuals with the Lesch Nyhan syndrome. Clonal lines of hypoxanthine phosphoribosyltransferase deficient neuroblastoma cells may therefore be of use in elucidating the mechanisms by which the enzyme defect leads to the neurologic dysfunction seen in children with this disease.

UR - http://www.scopus.com/inward/record.url?scp=0015734218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015734218&partnerID=8YFLogxK

M3 - Article

C2 - 4521214

AN - SCOPUS:0015734218

VL - 70

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 12

ER -